Expression of the cytoskeleton linker protein ezrin in human cancers

Clinical and Experimental Metastasis

Volumn 24, Issue 2, 2007, Pages 69-78

  Bruce, Benjamin ^a,b   Khanna, Gaurav ^a,b   Ren, Ling ^a   Landberg, Goran ^c   Jirström, Karin ^c   Powell, Charles ^d   Borczuk, Alain ^d   Keller, Evan T ^e   Wojno, Kirk J ^e   Meltzer, Paul ^f   Baird, Kristin ^f   McClatchey, Andrea ^g   Bretscher, Anthony ^h   Hewitt, Stephen M ^a   Khanna, Chand ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^c LUND UNIVERSITY HOSPITAL   (Sweden)

^d College of Physicians and Surgeons ^*  (United States)

^e UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^f NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^g MASSACHUSETTS GENERAL HOSPITAL CANCER CENTER   (United States)

^h Department of Obstetrics Gynecology   (United States)

Author keywords

Biomarker; Ezrin; Immunohistochemistry; Merlin; Prognosis; Tissue microarray

Indexed keywords

CYTOSKELETON PROTEIN; EZRIN; MERLIN;

ANGIOSARCOMA; ANIMAL CELL; ARTICLE; BREAST CANCER; CANCER; CANCER PATIENT; CANCER THERAPY; CHONDROSARCOMA; COLON CANCER; CONTROLLED STUDY; DRUG TARGETING; EPITHELIUM; EWING SARCOMA; FEMALE; FIBROSARCOMA; GASTROINTESTINAL CARCINOMA; HISTOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LEIOMYOSARCOMA; LUNG CANCER; MALE; MESENCHYME; MOUSE; NERVE SHEATH TUMOR; NEURILEMOMA; NONHUMAN; OVARY CANCER; PROSTATE CANCER; PROTEIN EXPRESSION; RHABDOMYOSARCOMA; SARCOMA; SYNOVIAL SARCOMA; TISSUE MICROARRAY;

CELL LINE, TUMOR; CYTOSKELETAL PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; NEOPLASMS; TISSUE ARRAY ANALYSIS;

EID: 34247603150     PISSN: 02620898     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10585-006-9050-x     Document Type: Article

References (33)

1. Gary R, Bretscher A (1995) Ezrin self-association involves binding of an N-terminal domain to a normally masked C-terminal domain that includes the F-actin binding site. Mol Biol Cell 6:1061-1075
2. Bretscher A, Edwards K, Fehon RG (2002) ERM proteins and merlin: integrators at the cell cortex. Nat Rev Mol Cell Biol 3:586-599
3. Yu Y et al (2004) Expression profiling identifies the cytoskeletal organizer ezrin and the developmental homeoprotein Six-1 as key metastatic regulators. Nat Med 10:175-181
4. Khanna C et al (2004) The membrane-cytoskeleton linker ezrin is necessary for osteosarcoma metastasis. Nat Med 10:182-186
5. Gautreau A, Poullet P, Louvard D Arpin M (1999) Ezrin a plasma membrane-microfilament linker, signals cell survival through the phosphatidylinositol 3-kinase/Akt pathway. Proc Natl Acad Sci USA 96:7300-7305
6. Hunter KW (2004) Ezrin, a key component in tumor metastasis. Trends Mol Med 10:201-204
7. Curto M, McClatchey AI (2004) Ezrin...a metastatic detERMinant? Cancer Cell 5:113-114
8. Algrain M, Turunen O, Vaheri A, Louvard D, Arpin M (1993) Ezrin contains cytoskeleton and membrane binding domains accounting for its proposed role as a membrane-cytoskeletal linker. J Cell Biol 120:129-139
9. Wan X, Mendoza A, Khanna C, Helman LJ (2005) Rapamycin inhibits ezrin-mediated metastatic behavior in a murine model of osteosarcoma. Cancer Res 65:2406-2411
10. Saotome I, Curto M, McClatchey AI (2004) Ezrin is essential for epithelial organization and villus morphogenesis in the developing intestine. Dev Cell 6:855-864
11. Ohtani K et al (2002) Ezrin, a membrane-cytoskeletal linking protein, is highly expressed in atypical endometrial hyperplasia and uterine endometrioid adenocarcinoma. Cancer Lett 179:79-86
12. Makitie T, Carpen O, Vaheri A, Kivela T (2001) Ezrin as a prognostic indicator and its relationship to tumor characteristics in uveal malignant melanoma. Invest Ophthalmol Vis Sci 42:2442-2449
13. Martin TA, Harrison G, Mansel RE, Jiang WG (2003) The role of the CD44/ezrin complex in cancer metastasis. Crit Rev Oncol Hematol 46:165-186
14. Tynninen O, Carpen O, Jaaskelainen J, Paavonen T, Paetau A (2004) Ezrin expression in tissue microarray of primary and recurrent gliomas. Neuropathol Appl Neurobiol 30:472-477
15. McClatchey AI (2003) Merlin and ERM proteins: unappreciated roles in cancer development? Nat Rev Cancer 3:877-883
16. Lallemand D, Curto M, Saotome I, Giovannini M, McClatchey AI (2003) NF2 deficiency promotes tumorigenesis and metastasis by destabilizing adherens junctions. Genes Dev 17:1090-1100
17. Nguyen R, Reczek D, Bretscher A (2001) Hierarchy of merlin and ezrin N- and C-terminal domain interactions in homo- and heterotypic associations and their relationship to binding of scaffolding proteins EBP50 and E3KARP. J Biol Chem 276:7621-7629
18. McClatchey AI, Giovannini M (2005) Membrane organization and tumorigenesis - the NF2 tumor suppressor, Merlin. Genes Dev 19:2265-2277
19. McClatchey AI et al (1998) Mice heterozygous for a mutation at the Nf2 tumor suppressor locus develop a range of highly metastatic tumors. Genes Dev 12:1121-1133
20. Nishizuka S et al (2003) Diagnostic markers that distinguish colon and ovarian adenocarcinomas: identification by genomic, proteomic, and tissue array profiling. Cancer Res 63:5243-5250
21. Borczuk AC et al (2003) Non-small-cell lung cancer molecular signatures recapitulate lung developmental pathways. Am J Pathol 163:1949-1960
22. Shah L et al (2004) Expression of syndecan-1 and expression of epidermal growth factor receptor are associated with survival in patients with nonsmall cell lung carcinoma. Cancer 101:1632-1638
23. Svensson S et al (2005) ERK phosphorylation is linked to VEGFR2 expression and Ets-2 phosphorylation in breast cancer and is associated with tamoxifen treatment resistance and small tumours with good prognosis. Oncogene 24:4370-4379
24. Rubin MA et al (2001) E-cadherin expression in prostate cancer: a broad survey using high-density tissue microarray technology. Hum Pathol 32:690-697
25. Hewitt SM (2004) Design, construction, and use of tissue microarrays. Methods Mol Biol 264:61-72
26. Berryman M, Franck Z, Bretscher A (1993) Ezrin is concentrated in the apical microvilli of a wide variety of epithelial cells whereas moesin is found primarily in endothelial cells. J Cell Sci 105(Pt 4):1025-1043
27. Brown MJ et al (2003) Chemokine stimulation of human peripheral blood T lymphocytes induces rapid dephosphorylation of ERM proteins, which facilitates loss of microvilli and polarization. Blood 102:3890-3899
28. Nakamura H, Ozawa H, (1996) Immunolocalization of CD44 and the ERM family in bone cells of mouse tibiae. J Bone Miner Res 11:1715-1722
29. Lach B, Gregor A, Rippstein P, Omulecka A (1999) Angiogenic histogenesis of stromal cells in hemangioblastoma: ultrastructural and immunohistochemical study. Ultrastruct Pathol 23:299-310
30. Bohling T et al (1996) Ezrin expression in stromal cells of capillary hemangioblastoma. An immunohistochemical survey of brain tumors. Am J Pathol 148:367-373
31. Weng WH, Ahlen J, Astrom K., Lui WO, Larsson C (2005) Prognostic impact of immunohistochemical expression of ezrin in highly malignant soft tissue sarcomas. Clin Cancer Res 11:6198-6204
32. Park PC et al (2003) Transcriptional profiling of medulloblastoma in children. J Neurosurg 99:534-541
33. Stokowski RP, Cox DR (2000) Functional analysis of the neurofibromatosis type 2 protein by means of disease-causing point mutations. Am J Hum Genet 66:873-891